吸烟暴露与COPD的性别差异:一项基于人群的队列研究
该研究基于哥本哈根普通人群研究,纳入47 231名男性和57 806名女性,评估吸烟量与COPD相关结局的性别交互作用。结果显示,女性吸烟量增加与气道阻塞、慢性支气管炎、呼吸困难、急性加重及呼吸死亡风险的关联均强于男性,提示女性对吸烟有害效应更易感。
要点
- 女性吸烟量与COPD相关结局的风险增加幅度大于男性。
- 女性吸烟≥50包年者急性加重风险显著高于男性。
- 女性呼吸死亡风险随吸烟量增加更陡峭。
核心结论
- 女性相比男性对吸烟在COPD发生和预后中的有害效应更易感。
研究设计与样本
- 基于哥本哈根普通人群研究的队列研究,纳入47 231名男性和57 806名女性。
- 采用logistic回归分析横断面关联,Cox比例风险回归分析纵向关联,并调整潜在混杂因素。
主要发现
- 吸烟量增加与气道阻塞(N=7367)、慢性支气管炎(N=9206)和呼吸困难(N=8541)的风险增加在女性中大于男性。
- 中位随访9.3年(15年随访期间),吸烟量增加与急性加重(事件=2756)、呼吸死亡(事件=711)和全因死亡(事件=10 658)的风险增加在女性中大于男性。
- 与从不吸烟者相比,女性10包年者急性加重调整HR为4.64(95%CI 2.83-7.61),≥50包年者为41.6(95%CI 28.8-60.2);男性相应为2.21(95%CI 0.92-5.32)和23.7(95%CI 12.9-43.5)。
- 女性呼吸死亡HR从10包年的2.04(95%CI 1.27-3.26)增至≥50包年的11.1(95%CI 7.39-16.8);男性从1.09(95%CI 0.62-1.92)增至5.66(95%CI 3.96-8.11)。
- 女性全因死亡HR从10包年的1.50(95%CI 1.34-1.67)增至≥50包年的3.53(95%CI 3.11-4.00);男性从1.62(95%CI 1.45-1.81)增至2.94(95%CI 2.69-3.21)。
临床怎么用
- 临床评估COPD风险时应考虑女性对吸烟更敏感,尤其需关注女性吸烟者的急性加重和死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sex discrepancies in the association between smoking and development and prognosis of chronic obstructive pulmonary disease (COPD) are controversial. We tested the hypothesis that females compared with males are more susceptible to the detrimental effects of smoking in relation to COPD. METHODS: We identified 47 231 males and 57 806 females from the Copenhagen General Population Study. Smoking amount was assessed with sex interaction against COPD-related outcomes, including the cross-sectional association with airway obstruction, chronic bronchitis and dyspnoea, assessed using logistic regression analyses, and longitudinal association with exacerbation and mortality, assessed using Cox proportional hazard regression adjusted for potential confounders. RESULTS: The increase in risk of airway obstruction (N=7367), chronic bronchitis (N=9206) and dyspnoea (N=8541) with higher smoking amount was greater in females compared with males. During 15 years' follow-up (median 9.3 years), the increase in risk of exacerbation (events=2756), respiratory mortality (events=711) and all-cause mortality (events=10 658) with higher smoking was greater for females compared with males. Compared with never-smokers, adjusted HRs for exacerbation increased from 4.64 (95% CI 2.83 to 7.61) in females with 10 pack-years to 41.6 (95% CI 28.8 to 60.2) in females with ≥50 pack-years, and from 2.21 (95% CI 0.92 to 5.32) in males with 10 pack-years to 23.7 (95% CI 12.9 to 43.5) in males with ≥50 pack-years. Corresponding HR increases for respiratory mortality were 2.04 (95% CI 1.27 to 3.26) to 11.1 (95% CI 7.39 to 16.8) in females and 1.09 (95% CI 0.62 to 1.92) to 5.66 (95% CI 3.96 to 8.11) in males, and for all-cause mortality, HR increases were 1.50 (95% CI 1.34 to 1.67) to 3.53 (95% CI 3.11 to 4.00) in females and 1.62 (1.45-1.81) to 2.94 (2.69-3.21) in males, respectively. CONCLUSIONS: Females seem more susceptible to the detrimental effects of smoking in development and prognosis of COPD compared with males.
引用
- Çolak, Nordestgaard, Lange, et al. Sex differences in COPD in relation to smoking exposure: a population-based cohort study. Thorax. 2025. PMID: 40185636. doi:10.1136/thorax-2024-222682
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。